ArticleCancer medicine2019

SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway.

Jilin Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.